To further validate the regulation of the EGFR/PI3K/AKT/GPX4 signalling axis by ORes in breast cancer cells, we performed Western blot analysis to assess the expression levels of key proteins in this pathway. This evidence concerns the gene AKT1 and breast carcinoma.